Stock Price
1,334.00
Daily Change
2.80 0.21%
Monthly
8.23%
Yearly
8.97%
Q2 Forecast
1,308.09

Dr.Reddys Laboratories reported INR37.7B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 9.63B 3.1B Dec/2025
Bharat Petroleum INR 994.08B 122.84B Dec/2025
Cipla INR 26.32B 2.79B Mar/2026
Dr.Reddys Laboratories INR 37.7B 1.54B Mar/2026
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
UPL INR 110.38B 43.65B Mar/2026